Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey L Greene

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Nature Chemical Biology|March 18, 2008
NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analysesKendall W Nettles, John B Bruning, German Gil, et al.
Molecular Cancer Research : MCR|April 5, 2020
The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast CancersIrida Kastrati, Stacey E P Joosten, Svetlana E Semina, et al.
Elife|May 16, 2022
Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in <i>ESR1</i> mutant breast cancer cellsDavid J Hosfield, Sandra Weber, Nan-Sheng Li, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Progesterone receptors drive advanced breast cancer phenotypes including circulating tumor- and stem-like cell expansion in the context of <i>ESR1</i> mutationThu H Truong, Noelle E Gillis, Amy R Dwyer, et al.
NPJ Breast Cancer|April 7, 2026
Progesterone receptors drive advanced breast cancer phenotypes including circulating tumor- and stem-like cell expansion in the context of ESR1 mutationThu H Truong, Noelle E Gillis, Amy R Dwyer, et al.
Elife|February 3, 2016
Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformationSean W Fanning, Christopher G Mayne, Venkatasubramanian Dharmarajan, et al.
Molecular Cancer Therapeutics|November 12, 2020
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast CancerBalkees Abderrahman, Philipp Y Maximov, Ramona F Curpan, et al.
Molecular Pharmacology|May 5, 2020
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer CellsPhilipp Y Maximov, Balkees Abderrahman, Yousef M Hawsawi, et al.
Oncotarget|February 18, 2015
14q32-encoded microRNAs mediate an oligometastatic phenotypeAbhineet Uppal, Sean C Wightman, Stephen Mallon, et al.
Oncotarget|February 14, 2018
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signalingHari Singhal, Marianne E Greene, Allison L Zarnke, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Nature Chemical Biology|March 18, 2008
NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analysesKendall W Nettles, John B Bruning, German Gil, et al.
Molecular Cancer Research : MCR|April 5, 2020
The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast CancersIrida Kastrati, Stacey E P Joosten, Svetlana E Semina, et al.
Elife|May 16, 2022
Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in <i>ESR1</i> mutant breast cancer cellsDavid J Hosfield, Sandra Weber, Nan-Sheng Li, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Progesterone receptors drive advanced breast cancer phenotypes including circulating tumor- and stem-like cell expansion in the context of <i>ESR1</i> mutationThu H Truong, Noelle E Gillis, Amy R Dwyer, et al.
NPJ Breast Cancer|April 7, 2026
Progesterone receptors drive advanced breast cancer phenotypes including circulating tumor- and stem-like cell expansion in the context of ESR1 mutationThu H Truong, Noelle E Gillis, Amy R Dwyer, et al.
Elife|February 3, 2016
Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformationSean W Fanning, Christopher G Mayne, Venkatasubramanian Dharmarajan, et al.
Molecular Cancer Therapeutics|November 12, 2020
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast CancerBalkees Abderrahman, Philipp Y Maximov, Ramona F Curpan, et al.
Molecular Pharmacology|May 5, 2020
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer CellsPhilipp Y Maximov, Balkees Abderrahman, Yousef M Hawsawi, et al.
Oncotarget|February 18, 2015
14q32-encoded microRNAs mediate an oligometastatic phenotypeAbhineet Uppal, Sean C Wightman, Stephen Mallon, et al.
Oncotarget|February 14, 2018
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signalingHari Singhal, Marianne E Greene, Allison L Zarnke, et al.
Pageof 8